Ekso Bionics Holdings, Inc. reporting persons Armistice Capital, LLC and Steven Boyd amend a Schedule 13G/A to disclose beneficial ownership of 187,151 shares of Common Stock, representing 4.99% of the class as stated in Item 4. The filing identifies Armistice Capital as investment manager of the Master Fund and Mr. Boyd as its managing member. The ownership figures are presented in the filing with an as of reference to 03/31/2026 on the cover.
ChronoScale Corp (CHRN) Schedule 13G/A amendment reports that Mink Brook Partners LP and related entities held 0 shares of Common Stock as of the close of business on May 14, 2026. The filing disclaims beneficial ownership by Mink Brook Capital GP LLC and William Mueller except for any pecuniary interest.